Ministers, related ministers, and other agencies who have the task and supervision function of any activities related to the Precursors are coordinated oversight according to its authority.
(2) The supervision as referred to in paragraph (1) is directed at:
a. Its precursor to the pharmaceutical and non-pharmaceutical industry interests;
B. Its Precursors to the benefit of education, the development of science and technology, and the health care;
c. Prevention of deviation and Precursor leaks;
D. protection to the community of the dangers of the Precursor abuse; and
e. The eradication of the Precursor dark circulation.
(3) The execution of the supervision as referred to in paragraph (1) is carried out by the supervising officer in accordance with the provisions of the laws.
(4) In conducting oversight as referred to in paragraph (3), the supervising officer authorized:
a. conduct a local check and/or take a Precursor example on the means of production, storage, storage and circulation;
B. checking messages/documents related to Precursor; and
(c). (c).
(5) The supervising officer in carrying out any surveillance activities must be supplemented with a duty letter in accordance with the provisions of the laws.
(6) The further provisions of the supervision as referred to in paragraph (2) are governed by the Minister and/or the relevant minister according to his authority.
Section 19
(1) Precursors derived from products of plants or animals may be established by the Minister as materials that are under supervision.
(2) In setting the Precursor as referred to in paragraph (1), the Minister is coordinating with the related minister.
Section 20
(1) In order of supervision, the Minister and related ministers can take administrative action.
(2) The administrative actions as referred to in paragraph (1) may be:
a. oral reprimand;
B. written reprimand;
c. temporary termination of activities; or
D. Permission revocation
(3) The further provisions of administrative actions as referred to in paragraph (1) and paragraph (2) are governed by the Minister and/or the associated minister according to his authority.
BAB IX
THE TRANSITION PROVISION
Section 21
The pharmaceutical industry, the non-pharmaceutical industry, the Large Traders of Baku Pharmaceutical Materials, distributors or registered importers, and institutes of science and technology development, adjust to the provisions of this Government Regulation in the most timeframe long 1 (one) year since the date of the promulgable of this Government Regulation.
BAB X
CLOSING PROVISIONS
Section 22
This Government Regulation shall come into effect on the date of the promulctest.
In order for everyone to know it, order the invitational of this Government Regulation with its placement in the State Sheet of the Republic of Indonesia.
Set in Jakarta
on April 5, 2010
PRESIDENT OF THE REPUBLIC OF INDONESIA,
SUSILO BAMBANG YUDHOYONO
Promulgated in Jakarta
on April 5, 2010
MINISTER OF LAW AND HUMAN RIGHTS
REPUBLIC OF INDONESIA,
PATRIALIST AKBAR
ATTACHMENT:
GROUP AND TYPE OF PRECURSORS
and the development of science and technology.
Section 3
The Precursor settings aim for:
a. protect the community from the danger of the Precursor abuse;
B. prevent and eradicate the Precursor dark circulation;
c. prevent the occurrence of a leak and the Precursor deviation; and
D. ensuring the availability of the Precursors for the pharmaceutical industry, the non-pharmaceutical industry, and the development of science and technology.
BAB II
THE TYPE AND PRECURSOR TYPE
Section 4
(1) The Precursor is classed in the Precursor Table I and Precursor Table II.
(2) The type of Precursor Table I and the type of Table II Precursors as set forth in the Attachment and are an inseparable part of this Government Regulation.
(3) The addition of materials and changes of the Precursors of Table I and Table II in the Attachment as referred to in paragraph (2) are set by the Minister after coordinating with the associated minister.
BAB III
ANNUAL NEED PLAN
Section 5
(1) The Minister is coordinating with the relevant minister composing the Precursor needs plan for the benefit of the pharmaceutical industry, the non-pharmaceutical industry, and the science and technology development institutions of each year.
(2) The plan of need as referred to in paragraph (1) is compiled based on the number of supplies, estimation of the needs and use of the Precursors nationally.
(3) The Minister based on the plan needs as referred to in paragraph (2) report to the international body in the field of Narcotics.
(4) The further provisions of the method of drafting the Precursor needs plan as referred to in paragraph (1) and verse (2) are governed by the Minister and/or the associated minister according to his authority.
BAB IV
PROCUREMENT
The Kesatu section
Common
Section 6
(1) Precursors of Precursors are carried out through domestic production and import.
(2) The Precursors as referred to in paragraph (1) can only be used for the purposes of the pharmaceutical industry, the non-pharmaceutical industry, and the development of science and technology.
(3) The potential tools that can be misused in the procurement and use of the Precursors as referred to in paragraph (1) and paragraph (2) are governed by the Minister and/or related ministers in accordance with its authority.
The Second Part
Production
Section 7
(1) The precursors can only be produced by industry who have had permissions in accordance with the provisions of the laws.
(2) The Production of Precursors for the pharmaceutical industry must be carried out in a manner of good production in accordance with the provisions of the laws.
(3) The precursors to the pharmaceutical industry must meet the standards of Indonesian Pharmacope and other standards.
(4) The precursors to the non-pharmaceutical industry must meet the requirements in accordance with the provisions of the laws.
Section 8
(1) Each Precursor is required to be labeled on any container or packaging.
(2) The Label on the container or the Precursor packaging as referred to in paragraph (1) may be written, image, combination of writing and image, or any other form included on the packaging or inserted in the packaging, pasted, or part of from the contai
